Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMPK Antibody (N-term) [APR11763G] | Login | DMPK Antibody (N-term) [APR11763G] | ||||||||||||||||
|
||||||||||||||||||
| EphA2 Antibody (C-term) [APR11849G] | Login | EphA2 Antibody (C-term) [APR11849G] | ||||||||||||||||
|
||||||||||||||||||
| EphA3 Antibody (N-term) [APR11854G] | Login | EphA3 Antibody (N-term) [APR11854G] | ||||||||||||||||
|
||||||||||||||||||
| EphA3 Antibody (C-term) [APR11853G] | Login | EphA3 Antibody (C-term) [APR11853G] | ||||||||||||||||
|
||||||||||||||||||
| EphB6 Antibody (N-term S45) [APR11874G] | Login | EphB6 Antibody (N-term S45) [APR11874G] | ||||||||||||||||
|
||||||||||||||||||
| JAKMIP1 Antibody (Center) [APR12445G] | Login | JAKMIP1 Antibody (Center) [APR12445G] | ||||||||||||||||
|
||||||||||||||||||
| EPHA2 Antibody (Center) [APR11850G] | Login | EPHA2 Antibody (Center) [APR11850G] | ||||||||||||||||
|
||||||||||||||||||
| EPHA5 Antibody [APR11861G] | Login | EPHA5 Antibody [APR11861G] | ||||||||||||||||
|
||||||||||||||||||
| DMPK Antibody (N-term) [APR11763G] | Login | DMPK Antibody (N-term) [APR11763G] | ||||||||||||||||
|
||||||||||||||||||
| PAX2 Antibody (Center) [APR12727G] | Login | PAX2 Antibody (Center) [APR12727G] | ||||||||||||||||
|
||||||||||||||||||
| Phospho-SHP2 (Y584) Antibody [APR12840G] | Login | Phospho-SHP2 (Y584) Antibody [APR12840G] | ||||||||||||||||
|
||||||||||||||||||
| Phospho-EphA2 (S897) Antibody [APR12830G] | Login | Phospho-EphA2 (S897) Antibody [APR12830G] | ||||||||||||||||
|
||||||||||||||||||
| PAX8 Antibody (Center) [APR12743G] | Login | PAX8 Antibody (Center) [APR12743G] | ||||||||||||||||
|
||||||||||||||||||
| PTH1R Antibody (N-Term) [APR13005G] | Login | PTH1R Antibody (N-Term) [APR13005G] | ||||||||||||||||
|
||||||||||||||||||
| PAX2 Antibody (Center) [APR12727G] | Login | PAX2 Antibody (Center) [APR12727G] | ||||||||||||||||
|
||||||||||||||||||
| SYP Antibody (C-term) [APR13649G] | Login | SYP Antibody (C-term) [APR13649G] | ||||||||||||||||
|
||||||||||||||||||
| SERPINI1 Antibody (N-term) [APR13292G] | Login | SERPINI1 Antibody (N-term) [APR13292G] | ||||||||||||||||
|
||||||||||||||||||
| S100A1 Antibody (C-term) [APR13180G] | Login | S100A1 Antibody (C-term) [APR13180G] | ||||||||||||||||
|
||||||||||||||||||
| SSTR1 Antibody (C-term) [APR13549G] | Login | SSTR1 Antibody (C-term) [APR13549G] | ||||||||||||||||
|
||||||||||||||||||
| HSC70 Interacting Protein HIP (ST13) Antibody [APR16725G] | Login | HSC70 Interacting Protein HIP (ST13) Antibody [APR16725G] | ||||||||||||||||
|
||||||||||||||||||
| IL3RB Antibody (C-term V759) [APR16831G] | Login | IL3RB Antibody (C-term V759) [APR16831G] | ||||||||||||||||
|
||||||||||||||||||
| IL3RA Antibody (C-term) [APR16829G] | Login | IL3RA Antibody (C-term) [APR16829G] | ||||||||||||||||
|
||||||||||||||||||
| IGHD Antibody (N-term) (Ascites) [APR16809G] | Login | IGHD Antibody (N-term) (Ascites) [APR16809G] | ||||||||||||||||
|
||||||||||||||||||
| IGHD Antibody (N-term) [APR16808G] | Login | IGHD Antibody (N-term) [APR16808G] | ||||||||||||||||
|
||||||||||||||||||
| HSP40 Antibody [APR16744G] | Login | HSP40 Antibody [APR16744G] | ||||||||||||||||
|
||||||||||||||||||


